13 completed. 13 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 13 |
| Phase 2 | 3 | Completed 3 |
Follow Sexuality: new trials by email Literature Review of Sexuality trials Research Report on Sexuality
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Swiss HCVree Trial grazoprevir/elbasvir, ribavirin, Behavioural Intervention - Hepatitis C, HIV | Phase 3 | Completed | University of Zurich | 150 | 2016-06-01 | 2018-08-31 |
| Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys. Kisspeptin-10 (metastin 45-54, Calbiochem, Darmstadt, Germany) - Reproductive Physiological Phenomena | Phase 3 | Completed | Ghulam Nabi | 30 | 2014-06-26 | 2017-09-18 |
| On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men Truvada, Placebo - HIV Infection | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 400 | 2012-01-01 | 2017-05-11 |
| The HJ MILE HIV Prevention Intervention for Post-incarcerated Men MILE intervention - HIV, Risk Reduction Behavior | Phase 3 | Completed | University of Southern California | 212 | 2011-07-01 | 2018-10-12 |
| Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen dutasteride 5 mg/day, Testosterone Undecanoate - Transgenderism, Hypogonadism | Phase 3 | Completed | Unita Complessa di Ostetricia e Ginecologia | 16 | 2008-11-04 | 2020-09-11 |
| No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks Video (group-delivered video-based intervention), HCT - HIV Infections | Phase 2 / Phase 3 | Completed | Centers for Disease Control and Prevention | 370 | 2008-06-01 | 2010-03-09 |
| Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer pilocarpine hydrochloride, placebo - Breast Cancer, Vaginal Dryness | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 201 | 2006-12-01 | 2016-08-12 |
| Testosterone and Its Metabolites in GID testosterone undecanoate alone, testosterone undecanoate plus letrozole, testosterone undecanoate plus dutasteride - Transsexualism | Phase 3 | Completed | Unita Complessa di Ostetricia e Ginecologia | 15 | 2005-05-01 | 2018-03-21 |
| Voucher-Based Incentives in a Prevention Setting Voucher-Based Reinforcement Therapy - Substance-related Disorders | Phase 2 / Phase 3 | Completed | Friends Research Institute, Inc. | 131 | 2005-04-01 | 2013-08-01 |
| Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors therapeutic testosterone, placebo - Cancer Survivor, Sexual Dysfunction | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 150 | 2004-04-01 | 2016-07-13 |
| Efficacy of Gynodian® Depot in Women With Impaired Well-being Gynodian® Depot (BAY86-5032), BAY86-4980 - Hormone Replacement Therapy | Phase 3 | Completed | Bayer | 140 | 2002-05-01 | 2014-12-30 |
| Community Intervention Trial for Youth (CITY) Study Community-Level Intervention - HIV Infections | Phase 2 / Phase 3 | Completed | Centers for Disease Control and Prevention | 12000 | 1996-10-01 | 2012-09-27 |
| HIV Prevention Counseling for Men Who Have Sex With Men Behavioral intervention, Risk-reduction counseling - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 4350 | 2008-09-09 |
HIV Infections (4) · Homosexuality (4) · Homosexuality, Male (2) · Sexual Dysfunction, Physiological (2) · Transsexualism (2) · Bisexuality (1) · Breast Neoplasms (1) · Hepatitis C (1) · Hypogonadism (1) · Risk Reduction Behavior (1) · Risk-Taking (1) · Substance-Related Disorders (1) · Unsafe Sex (1)
Behavior (13) · Sexual Behavior (13) · Genital Diseases (6) · Urogenital Diseases (6) · Blood-Borne Infections (5) · Communicable Diseases (5) · Infections (5) · RNA Virus Infections (5) · Virus Diseases (5) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Lentivirus Infections (4) · Retroviridae Infections (4) · Sexually Transmitted Diseases (4)
Dutasteride (2) · testosterone undecanoate (2) · Behavior Therapy (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · KISS1 protein, human (1) · Letrozole (1) · Pilocarpine (1) · Ribavirin (1) · Testosterone Propionate (1) · Videotape Recording (1) · elbasvir (1) · elbasvir-grazoprevir drug combination (1) · grazoprevir (1)
Alliance for Clinical Trials in Oncology (2) · Centers for Disease Control and Prevention (2) · Unita Complessa di Ostetricia e Ginecologia (2) · ANRS, Emerging Infectious Diseases (1) · Bayer (1) · Friends Research Institute, Inc. (1) · Ghulam Nabi (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University of Southern California (1) · University of Zurich (1)
United States (7) · Canada (1) · France (1) · Italy (1) · Pakistan (1) · Switzerland (1)
Charles L. Loprinzi, MD (2) · Carolyn A Guenther-Grey, M.A. (1) · Cathy J Reback, Ph.D. (1) · Chesney M, Coates T (1) · Cristina M Meriggiola, MD (1) · Dominique L Braun, MD (1) · Jesse B Fletcher, Ph.D. (1) · Koblin B (1) · Lydia O'Donnell, PhD (1) · Muhammad Shahab, PhD (1) · Ricky Bluthenthal, Ph.D. (1)
PMID 15234855, PMID 17470735, PMID 19820030, PMID 20667681, PMID 21128876, PMID 21702402, PMID 21976724, PMID 22880545, PMID 26624850, PMID 27115618, PMID 27516073, PMID 28747274, PMID 29124541, PMID 29229440, PMID 29541914, PMID 29541962, PMID 30046307, PMID 30107485, PMID 30107494, PMID 31533734, PMID 31784343, PMID 32761122, PMID 33823783, PMID 35404384, PMID 39100527
5UR6PS001098 (1), R01DA015990 (1)